期刊文献+

促红细胞生成素及其受体的研究进展 被引量:6

下载PDF
导出
摘要 促红细胞生成素(EPO)作为一种临床常用促造血因子为人们熟知,而最新的一系列研究表明,EPO尚存在多种非造血方面的作用,包括抗凋亡作用、促血管生成作用、神经保护作用等,这可能对多系统如肾脏系统、心血管系统、神经系统等具有潜在的应用价值。通过对EPO的生理作用、结构、功能分析,重点阐述了目前已经发现的多种EPO相关受体的结构与功能及其作用通路,试图通过丰富的分子生物学层面的资料,解释EPO这一经典促造血因子能够产生多器官良性作用的原因。论述了目前EPO除促造血功能外多器官功能在各个系统中的研究进展,为EPO的进一步深入研究及临床应用提出了新的思路。
出处 《临床荟萃》 CAS 2014年第5期585-589,共5页 Clinical Focus
基金 黑龙江省科学技术计划项目(2005G1402-00)
  • 相关文献

参考文献47

  • 1Noguchi CT, Wang L, Rogers HM, et al. Survival and proliferative roles of erythropoietin beyond the erythroid lineage[J]. Expert Rev Mol Med, 2008,10 : e36.
  • 2Paliege A, Rosenberger C, Bondke A, et al. Hypoxia-inducible factor-2a-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization[J]. Kidney Int, 2010,77 (4) = 312-318.
  • 3Xiao L,Li Z,Xu P,et al. The expression of epor in renal cortex during postnatal development [J]. PLoS One, 2012, 7 ( 7 ) e41993.
  • 4Nalbant D,Saleh M, Goldman FD, et al. Evidence of receptor- mediated elimination of erythropoietin by analysis of erythropoietin receptor mRNA expression in bone marrow and erythropoietin clearance during anemia[J]. J Pharmacol Exp Ther, 2010,333 (2) : 528-532.
  • 5Jelkmann W. Molecular biology of erythropoietin[J]. Intern Med,2004,43(8) :649-659.
  • 6Jelkmann W. Erythropoietin after a century of research: younger than ever[J]. Eur J Haematol,2007,78(3) :188-205.
  • 7Jelkmann W, Bohlius J, Hallek M, et al. The erythropoietin receptor in normal and cancer tissues [J]. Crit Rev Oncol Hematol , 2008 , 6 7 (1) :39-61.
  • 8Barber DL,Beatti BK, Mason JM, et al. A common epitope is shared by activated signal transducer and activator of transcription-5 ( STAT5 ) and the phosphorylated erythropoietin receptor:implications for the docking model of STAT aetivation[J]. Blood,2001,97(8) :2230-2237.
  • 9Nairz M, Schroll A, Moscheh AR, et al. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-nB-inducible immune pathways [J]. Immunity,2011,34(1) :61-74.
  • 10Broxmeyer HE. grythropoietin surprises: an immune saga[J]. Immunity,2011,34(1) :6-7.

二级参考文献10

  • 1Pallet N, Bouvier N, Legendre C. Antiapoptotic properties of recombinant human erythropoietin protects against tubular cyclosporine toxicity [ J ]. Pharmaol Res ,2010,61 ( 1 ) :71 - 75.
  • 2Bahlmann FH, Fliser D. Erythropoietin and renoprotection [ J ]. Curr Opin Nephrol Hypertens,2009,18( 1 ) :15 -20.
  • 3Mehta RL, Kellum JA, Shah SV, et aL Acute kidney injury network : Report of an initiative to improve outcomes in acute kidney injury[ J]. Crit Care,2007,11 (2) :R31.
  • 4丁洁.薄基膜肾病[M]//易著文.实用小儿肾脏病手册.北京:人民卫生出版社,2005:474-476.
  • 5Shuai H, Zhang J, Yu Y, et al. Expression of EPO receptor in pancreatic cells and its effect on cell apoptosis[ J]. J Huazhong Univ Sci Technolog Med Sci,2008,28( 1 ) :49 -51.
  • 6MacRedmond R, Singhera GK, Dorscheid DR. Erythropoietin inhibits re- spiratory epithelial cell apoptosis in a model of acute lung injury[ J]. Eur Respir J,2009,33(6) :1403 - 1414.
  • 7Brines M. The therapeutic potential of erythropoiesis - stimulating agents for tissue protection: A tale of two receptors[ J]. Blood Purif,2010,29 (2) :86 -92.
  • 8Rezaeian F, Wettstein R, Egger JF, et al. Erythropoietin - induced upregulation of endothelial nitric oxide synthase but not vascular endothelial growth factor prevents musculocutaneous tissue from ischemic damage [ J]. Lab Invest .2010,90( 1 ) :40 -51.
  • 9季丽娜,曹力,陈大坤,陈朝英.儿童肾衰竭51例[J].实用儿科临床杂志,2010,25(17):1333-1335. 被引量:5
  • 10李志辉,易著文,何小解,吴小川.激素耐药型和激素依赖型肾病患儿肾脏病理计量分析[J].中华儿科杂志,2001,39(8):449-452. 被引量:53

共引文献5

同被引文献39

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部